A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer

Clinical trial NCT05586516 · COMPLETED

Trial details

NCT number: NCT05586516
Sponsor: iOnctura
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Cancer

Start date: 2022-10-10
Primary completion: 2025-08-18
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.